One study addressed the antitumor effects of diltiazem, which reduced colony formation, cell migration, and EMT by increasing GDF-15 expression level through inhibiting its proteolytic degradation in different breast cancer cell lines in vitro. The gene discussed is GDF15; the disease is breast carcinoma.